InsiderClue
← All stocks

Xenon Pharmaceuticals Inc.

XENE Net selling
CIK 0001582313 #1255 in the set updated 17 Sep 2026
Bought (120 mo)
$2.62M
out of their own pocket, the only kind of buying there is
Sold (120 mo)
$53.66M
$3.26M on a plan · $38.28M straight out of an exercise
Sold at will
$12.11M
33 of 111 sales
Net
−$51.05M
−$9.50M against sales at will

By person

23 insiders · 217 transactions
2.6×

Ian Mortimer holds only 2.6 times base salary in stock. $2.09M of shares against $786.00K in salary for 2025.

Salary from the company's own proxy. The shares are what Ian Mortimer last reported holding, valued at $60.98, the price Common Shares was last bought or sold at on the open market here, on 28 Aug 2026.

Insider
Role
Bought
Sold
Net
Holding
Of company
Worth
Change
MORTIMER IAN
PRESIDENT & CEO
$43.23K (2)
$24.82M (25) scheduled
−$24.78M
34,223
0.0353%
$2.09M
+545.7%
PIMSTONE SIMON N.
Director
$17.40K (1)
$14.96M (34)
−$14.95M
6,000
0.0062%
$365.86K
−97.2%
EMPFIELD JAMES R.
EVP, Drug Discovery
$24.82K (1)
$3.78M (5) scheduled
−$3.75M
10,000
0.0103%
$609.77K
—
ROBIN SHERRINGTON
EVP, Strategy & Innovation
—
$3.61M (11) scheduled
−$3.61M
8,398
0.0087%
$512.08K
+108.8%
BVF PARTNERS L P/IL entity
10% owner
$2.05M (28)
—
+$2.05M
59,464
0.0614%
$3.63M
−96.9%
AULIN SHERRY
Chief Financial Officer
—
$1.38M (3) scheduled
−$1.38M
0
0.0000%
$0.00
—
GANNON STEVEN
Director
$42.27K (1)
$1.24M (6)
−$1.20M
1,870
0.0019%
$114.03K
—
PATOU GARY
Director
$35.84K (2)
$1.17M (9) scheduled
−$1.13M
29,798
0.0308%
$1.82M
+647.6%
Svoronos Dawn
Director
$140.77K (1)
$967.50K (1)
−$826.73K
31,373
0.0324%
$1.91M
—
KENNEY CHRISTOPHER JOHN
Chief Medical Officer
$20.17K (1)
$694.76K (5) scheduled
−$674.60K
2
<0.0001%
$121.95
+100.0%
HOLLER FRANK A
Director
—
$649.32K (7)
−$649.32K
143,653
0.1483%
$8.76M
−1.5%
DiFabio Andrea
Chief Legal Officer
—
$230.81K (2) scheduled
−$230.81K
7,301
0.0075%
$445.19K
—
Von Seggern Christopher
Chief Commercial Officer
$97.60K (1)
—
+$97.60K
4,000
0.0041%
$243.91K
—
GAROFALO ELIZABETH A.
Director
—
$95.58K (1) scheduled
−$95.58K
2,645
0.0027%
$161.28K
—
AZAB MOHAMMAD
Director
$81.14K (5)
$214.18 (1)
+$80.93K
74,225
0.0766%
$4.53M
+1,403%
Cannon Gillian
Director
—
$63.24K (1) scheduled
−$63.24K
1,455
0.0015%
$88.72K
—
Hayden Michael R
Director
$41.25K (1)
—
+$41.25K
208,282
0.2151%
$12.70M
+169.4%
SCHELLER RICHARD H
Director
$19.95K (1)
—
+$19.95K
7,000
0.0072%
$426.84K
—
WINQUIST RAYMOND
Head, Translational Research
$3.00K (1)
—
+$3.00K
1,000
0.0010%
$60.98K
—
TARNOW MICHAEL M
Director
—
—
—
77,942
0.0805%
$4.75M
+41.3%
COHEN CHARLES J.
VP, Biology
—
—
—
6,550
0.0068%
$399.40K
—
Machado Patrick
Director
—
—
—
2,645
0.0027%
$161.28K
—
Gover Justin D.
Director
—
—
—
2,645
0.0027%
$161.28K
—

Individual transactions

217
Insider
Date
Role
Action
Shares
Price
Amount
Svoronos Dawn
1 Sep 2026
Director
Exercised, kept
5,144
$8.15
$41.92K
KENNEY CHRISTOPHER JOHN
28 Aug 2026
Chief Medical Officer
Sold on a plan
700
$60.98
$42.68K
KENNEY CHRISTOPHER JOHN
28 Aug 2026
Chief Medical Officer
Sold on a plan
6,368
$60.17
$383.15K
GANNON STEVEN
11 Aug 2026
Director
Sell
10,000
$64.06
$640.55K
Cannon Gillian
5 Jun 2026
Director
Sold on a plan
1,190
$53.14
$63.24K
PATOU GARY
5 Jun 2026
Director
Sold on a plan
1,322
$53.14
$70.25K
GANNON STEVEN
12 May 2026
Director
Exercised, kept
3,500
$7.38
$25.83K
MORTIMER IAN
13 Mar 2026
PRESIDENT & CEO
Sold on a plan
7,308
$55.23
$403.58K
DiFabio Andrea
13 Mar 2026
Chief Legal Officer
Sold on a plan
1,342
$55.23
$74.11K
KENNEY CHRISTOPHER JOHN
13 Mar 2026
Chief Medical Officer
Sold on a plan
1,410
$55.23
$77.87K
MORTIMER IAN
10 Mar 2026
PRESIDENT & CEO
Sold on a plan
11,269
$60.11
$677.36K
DiFabio Andrea
10 Mar 2026
Chief Legal Officer
Sold on a plan
2,607
$60.11
$156.70K
KENNEY CHRISTOPHER JOHN
10 Mar 2026
Chief Medical Officer
Sold on a plan
2,771
$60.11
$166.56K
MORTIMER IAN
9 Mar 2026
PRESIDENT & CEO
Sold after exercise
65,000
$62.06
$4.03M
MORTIMER IAN
9 Mar 2026
PRESIDENT & CEO
Sold after exercise
61,652
$60.08
$3.70M
MORTIMER IAN
9 Mar 2026
PRESIDENT & CEO
Sold after exercise
43,348
$59.26
$2.57M
MORTIMER IAN
9 Mar 2026
PRESIDENT & CEO
Sold after exercise
2,449
$61.26
$150.03K
MORTIMER IAN
9 Mar 2026
PRESIDENT & CEO
Sold after exercise
10,072
$60.47
$609.05K
MORTIMER IAN
9 Mar 2026
PRESIDENT & CEO
Sold after exercise
12,479
$59.50
$742.50K
MORTIMER IAN
9 Mar 2026
PRESIDENT & CEO
Sold after exercise
21,515
$60.49
$1.30M
MORTIMER IAN
9 Mar 2026
PRESIDENT & CEO
Sold after exercise
31,694
$59.88
$1.90M
MORTIMER IAN
9 Mar 2026
PRESIDENT & CEO
Sold after exercise
21,791
$58.81
$1.28M
MORTIMER IAN
2 Jan 2026
PRESIDENT & CEO
Sold after exercise
2,062
$44.93
$92.65K
MORTIMER IAN
2 Jan 2026
PRESIDENT & CEO
Sold after exercise
37,938
$44.40
$1.68M
MORTIMER IAN
8 Dec 2025
PRESIDENT & CEO
Sold on a plan
2,010
$46.32
$93.10K
MORTIMER IAN
8 Dec 2025
PRESIDENT & CEO
Sold on a plan
8,820
$45.59
$402.10K
MORTIMER IAN
5 Dec 2025
PRESIDENT & CEO
Sold on a plan
14,375
$45.03
$647.31K
MORTIMER IAN
28 Nov 2025
PRESIDENT & CEO
Sold on a plan
97
$45.01
$4.37K
MORTIMER IAN
1 Oct 2025
PRESIDENT, CEO & INTERIM CFO
Sold after exercise
25,000
$40.16
$1.00M
GANNON STEVEN
5 Jun 2025
Director
Sell
3
$30.48
$91.44
GANNON STEVEN
14 May 2025
Director
Exercised, kept
5,144
$12.57
$64.66K
MORTIMER IAN
27 Jan 2025
PRESIDENT & CEO
Sold after exercise
1,149
$41.07
$47.19K
MORTIMER IAN
27 Jan 2025
PRESIDENT & CEO
Sold after exercise
15,166
$40.46
$613.62K
MORTIMER IAN
24 Jan 2025
PRESIDENT & CEO
Sold after exercise
22,468
$40.20
$903.21K
MORTIMER IAN
23 Jan 2025
PRESIDENT & CEO
Sold after exercise
16,217
$40.08
$649.98K
AULIN SHERRY
18 Dec 2024
Chief Financial Officer
Sold after exercise
11,510
$41.19
$474.10K
AULIN SHERRY
18 Dec 2024
Chief Financial Officer
Sold after exercise
7,199
$41.23
$296.81K
PATOU GARY
22 Nov 2024
Director
Sold after exercise
2,040
$41.05
$83.74K
PATOU GARY
22 Nov 2024
Director
Sold after exercise
2,851
$41.11
$117.20K
GAROFALO ELIZABETH A.
8 Mar 2024
Director
Sold after exercise
2,092
$45.69
$95.58K
GANNON STEVEN
7 Mar 2024
Director
Sell
2,000
$46.20
$92.40K
GANNON STEVEN
7 Mar 2024
Director
Sell
5,000
$46.30
$231.51K
GANNON STEVEN
7 Mar 2024
Director
Sell
5,000
$46.25
$231.25K
GANNON STEVEN
7 Mar 2024
Director
Sell
1,000
$46.45
$46.45K
ROBIN SHERRINGTON
7 Mar 2024
EVP, Strategy & Innovation
Sold after exercise
6,118
$46.30
$283.26K
ROBIN SHERRINGTON
7 Mar 2024
EVP, Strategy & Innovation
Sold after exercise
1,019
$46.15
$47.03K
AZAB MOHAMMAD
19 Dec 2023
Director
Exercised, kept
3,497
$9.85
$34.45K
AZAB MOHAMMAD
19 Dec 2023
Director
Exercised, kept
823
$9.85
$8.11K
PATOU GARY
13 Dec 2023
Director
Sold after exercise indirect
7,598
$41.05
$311.90K
PATOU GARY
13 Dec 2023
Director
Sold after exercise
3,977
$39.84
$158.44K
PATOU GARY
13 Dec 2023
Director
Sold after exercise
2,303
$39.10
$90.05K
PATOU GARY
13 Dec 2023
Director
Sold after exercise
5,100
$38.94
$198.59K
Svoronos Dawn
24 Aug 2023
Director
Sell
25,000
$38.70
$967.50K
PIMSTONE SIMON N.
1 Jun 2023
Director
Sold after exercise
24,255
$38.78
$940.61K
PIMSTONE SIMON N.
1 Jun 2023
Director
Sold after exercise
7,458
$38.97
$290.64K
PIMSTONE SIMON N.
31 May 2023
Director
Sold after exercise
26,856
$38.69
$1.04M
PIMSTONE SIMON N.
31 May 2023
Director
Sold after exercise
23,670
$38.81
$918.63K
PIMSTONE SIMON N.
31 May 2023
Director
Sold after exercise
12,000
$38.53
$462.36K
PIMSTONE SIMON N.
30 May 2023
Director
Sell
19,000
$39.90
$758.10K
PIMSTONE SIMON N.
30 May 2023
Director
Sell
18,006
$38.63
$695.57K
MORTIMER IAN
24 May 2023
PRESIDENT & CEO
Sold after exercise
1,407
$41.49
$58.38K
MORTIMER IAN
24 May 2023
PRESIDENT & CEO
Sold after exercise
13,179
$41.37
$545.22K
MORTIMER IAN
24 May 2023
PRESIDENT & CEO
Sold after exercise
17,069
$41.44
$707.34K
KENNEY CHRISTOPHER JOHN
24 Mar 2023
Chief Medical Officer
Sell
700
$35.01
$24.51K
PIMSTONE SIMON N.
7 Mar 2023
Director
Sold after exercise
8,242
$36.94
$304.46K
PIMSTONE SIMON N.
7 Mar 2023
Director
Sold after exercise
10,990
$37.01
$406.74K
AZAB MOHAMMAD
12 Dec 2022
Director
Exercised, kept
3,086
$2.68
$8.27K
PATOU GARY
25 Nov 2022
Director
Sold after exercise
1,937
$34.79
$67.39K
PATOU GARY
23 Nov 2022
Director
Sell
2,057
$34.33
$70.61K
AULIN SHERRY
2 Sep 2022
Chief Financial Officer
Sold after exercise
15,355
$39.57
$607.60K
ROBIN SHERRINGTON
1 Sep 2022
EVP, Strategy & Innovation
Sold after exercise
8,776
$38.80
$340.51K
ROBIN SHERRINGTON
1 Sep 2022
EVP, Strategy & Innovation
Sold after exercise
35,103
$38.03
$1.33M
ROBIN SHERRINGTON
31 Aug 2022
EVP, Strategy & Innovation
Sold after exercise
21,352
$38.57
$823.55K
PIMSTONE SIMON N.
16 Aug 2022
Director
Sell
20,000
$38.87
$777.40K
PIMSTONE SIMON N.
16 Aug 2022
Director
Sell
32,058
$38.29
$1.23M
PIMSTONE SIMON N.
15 Aug 2022
Director
Sell
33,942
$37.76
$1.28M
PIMSTONE SIMON N.
12 Aug 2022
Director
Sell
1,000
$39.15
$39.15K
PIMSTONE SIMON N.
12 Aug 2022
Director
Sell
47,000
$38.60
$1.81M
PIMSTONE SIMON N.
12 Aug 2022
Director
Sell
43,135
$37.91
$1.64M
EMPFIELD JAMES R.
12 Aug 2022
EVP, Drug Discovery
Sold after exercise
21,875
$38.68
$846.13K
EMPFIELD JAMES R.
12 Aug 2022
EVP, Drug Discovery
Sold after exercise
35,868
$38.08
$1.37M
PIMSTONE SIMON N.
8 Mar 2022
Director
Sell
2,500
$30.50
$76.25K
PIMSTONE SIMON N.
8 Mar 2022
Director
Sell
2,500
$30.55
$76.38K
PIMSTONE SIMON N.
8 Mar 2022
Director
Sell
2,500
$30.20
$75.50K
PIMSTONE SIMON N.
8 Mar 2022
Director
Sell
2,500
$30.10
$75.25K
PIMSTONE SIMON N.
8 Mar 2022
Director
Sell
2,500
$3.80
$9.50K
PIMSTONE SIMON N.
8 Mar 2022
Director
Sell
2,051
$30.60
$62.76K
EMPFIELD JAMES R.
7 Mar 2022
EVP, Drug Discovery
Sold after exercise
31,048
$30.54
$948.21K
EMPFIELD JAMES R.
7 Mar 2022
EVP, Drug Discovery
Sold after exercise
1,805
$30.62
$55.27K
PIMSTONE SIMON N.
7 Mar 2022
Director
Sold after exercise
2,500
$30.55
$76.38K
PIMSTONE SIMON N.
7 Mar 2022
Director
Sold after exercise
7,500
$30.50
$228.75K
PIMSTONE SIMON N.
7 Mar 2022
Director
Sold after exercise
2,500
$30.52
$76.30K
PIMSTONE SIMON N.
7 Mar 2022
Director
Sold after exercise
4,516
$30.44
$137.47K
PIMSTONE SIMON N.
7 Mar 2022
Director
Sold after exercise
4,516
$30.45
$137.51K
PIMSTONE SIMON N.
7 Mar 2022
Director
Sold after exercise
4,517
$30.49
$137.72K
PIMSTONE SIMON N.
7 Mar 2022
Director
Sold after exercise
5,037
$30.60
$154.13K
EMPFIELD JAMES R.
4 Mar 2022
EVP, Drug Discovery
Sold after exercise
18,315
$30.79
$563.92K
ROBIN SHERRINGTON
4 Mar 2022
EVP, Strategy & Innovation
Sold after exercise
5,000
$30.23
$151.15K
ROBIN SHERRINGTON
4 Mar 2022
EVP, Strategy & Innovation
Sold after exercise
5,000
$31.05
$155.25K
ROBIN SHERRINGTON
4 Mar 2022
EVP, Strategy & Innovation
Sold after exercise
5,000
$30.15
$150.75K
ROBIN SHERRINGTON
4 Mar 2022
EVP, Strategy & Innovation
Sold after exercise
6,710
$30.56
$205.06K
PIMSTONE SIMON N.
4 Mar 2022
Director
Sold after exercise
4,793
$30.56
$146.47K
PIMSTONE SIMON N.
4 Mar 2022
Director
Sold after exercise
4,532
$30.66
$138.95K
KENNEY CHRISTOPHER JOHN
21 Jan 2022
Chief Medical Officer
Buy
700
$28.81
$20.17K
AZAB MOHAMMAD
15 Dec 2021
Director
Exercised, kept
3,086
$3.67
$11.33K
PATOU GARY
8 Dec 2021
Director
Exercised, kept
2,057
$3.67
$7.55K
Von Seggern Christopher
6 Dec 2021
Chief Commercial Officer
Buy
4,000
$24.40
$97.60K
PIMSTONE SIMON N.
15 Nov 2021
Director
Sell
17,557
$31.33
$550.06K
ROBIN SHERRINGTON
28 May 2021
EVP, Strategy & Innovation
Sold after exercise
2,912
$18.81
$54.77K
ROBIN SHERRINGTON
28 May 2021
EVP, Strategy & Innovation
Sold after exercise
3,155
$18.81
$59.35K
HOLLER FRANK A
27 May 2021
Director
Sold after exercise
8,485
$18.68
$158.50K
HOLLER FRANK A
27 May 2021
Director
Sold after exercise
2,579
$18.69
$48.20K
PIMSTONE SIMON N.
24 May 2021
CEO
Exercised, kept
22,633
$3.76
$85.10K
Hayden Michael R
18 May 2021
Director
Exercised, kept
3,500
$3.85
$13.48K
TARNOW MICHAEL M
18 May 2021
Director
Exercised, kept
5,144
$3.67
$18.88K
TARNOW MICHAEL M
18 May 2021
Director
Exercised, kept
1,028
$3.67
$3.77K
TARNOW MICHAEL M
18 May 2021
Director
Exercised, kept
2,057
$3.87
$7.96K
Hayden Michael R
18 Feb 2021
Director
Exercised, kept indirect
30,864
$2.68
$82.72K
Hayden Michael R
18 Feb 2021
Director
Exercised, kept indirect
10,288
$3.67
$37.76K
Hayden Michael R
16 Feb 2021
Director
Exercised, kept
5,144
$2.68
$13.79K
AZAB MOHAMMAD
15 Dec 2020
Director
Exercised, kept
3,086
$3.76
$11.60K
PATOU GARY
28 Oct 2020
Director
Exercised, kept
2,057
$3.76
$7.73K
TARNOW MICHAEL M
28 Oct 2020
Director
Exercised, kept
5,144
$3.76
$19.34K
TARNOW MICHAEL M
28 Oct 2020
Director
Exercised, kept
5,144
$3.76
$19.34K
TARNOW MICHAEL M
9 Jun 2020
Director
Exercised, kept
5,144
$3.52
$18.11K
PIMSTONE SIMON N.
1 Jun 2020
CEO
Sell
3,000
$14.43
$43.29K
ROBIN SHERRINGTON
1 Jun 2020
EVP, Strategy & Innovation
Exercised, kept
8,230
$3.56
$29.30K
PIMSTONE SIMON N.
29 May 2020
CEO
Sell
5,000
$13.99
$69.95K
HOLLER FRANK A
29 May 2020
Director
Exercised, kept
3,086
$3.56
$10.99K
PIMSTONE SIMON N.
26 May 2020
CEO
Exercised, kept
6,172
$3.56
$21.97K
AZAB MOHAMMAD
16 Dec 2019
Director
Exercised, kept
3,086
$3.56
$10.99K
PATOU GARY
4 Dec 2019
Director
Exercised, kept
2,057
$3.56
$7.32K
TARNOW MICHAEL M
21 Nov 2019
Director
Exercised, kept
2,057
$3.51
$7.22K
TARNOW MICHAEL M
21 Nov 2019
Director
Exercised, kept
5,144
$3.56
$18.31K
HOLLER FRANK A
20 Sep 2019
Director
Sell
5,206
$9.39
$48.88K
PIMSTONE SIMON N.
20 Sep 2019
CEO
Sell
10,395
$9.51
$98.86K
HOLLER FRANK A
19 Sep 2019
Director
Sell
7,600
$9.27
$70.45K
HOLLER FRANK A
18 Sep 2019
Director
Sell
4,368
$9.28
$40.54K
HOLLER FRANK A
17 Sep 2019
Director
Sell
5,069
$9.32
$47.24K
PIMSTONE SIMON N.
17 Sep 2019
CEO
Exercised, kept
12,345
$3.38
$41.73K
PIMSTONE SIMON N.
17 Sep 2019
CEO
Exercised, kept
9,259
$3.07
$28.43K
PIMSTONE SIMON N.
17 Sep 2019
CEO
Exercised, kept
36,008
$3.70
$133.23K
AZAB MOHAMMAD
13 Sep 2019
Director
Sell
23
$9.31
$214.18
ROBIN SHERRINGTON
12 Sep 2019
EVP, Strategy & Innovation
Exercised, kept
6,172
$3.07
$18.95K
HOLLER FRANK A
12 Sep 2019
Director
Exercised, kept
25,720
$3.00
$77.16K
HOLLER FRANK A
12 Sep 2019
Director
Exercised, kept
3,086
$3.07
$9.47K
HOLLER FRANK A
12 Sep 2019
Director
Exercised, kept
3,086
$3.70
$11.42K
TARNOW MICHAEL M
21 May 2019
Director
Exercised, kept
2,057
$3.21
$6.60K
Hayden Michael R
19 Mar 2019
Director
Exercised, kept indirect
20,576
$3.38
$69.55K
PATOU GARY
14 Dec 2018
Director
Exercised, kept
2,057
$3.07
$6.31K
COHEN CHARLES J.
11 Dec 2018
VP, Biology
Exercised, kept
4,115
$3.07
$12.63K
AZAB MOHAMMAD
6 Dec 2018
Director
Exercised, kept
3,086
$3.07
$9.47K
AZAB MOHAMMAD
21 Jun 2018
Director
Exercised, kept
10,288
$3.70
$38.07K
TARNOW MICHAEL M
21 Jun 2018
Director
Exercised, kept
5,144
$3.07
$15.79K
TARNOW MICHAEL M
21 Jun 2018
Director
Exercised, kept
2,057
$3.66
$7.53K
TARNOW MICHAEL M
21 Jun 2018
Director
Exercised, kept
5,144
$3.70
$19.03K
PATOU GARY
14 Jun 2018
Director
Exercised, kept
8,230
$3.70
$30.45K
ROBIN SHERRINGTON
15 Mar 2018
EVP Bus. & Corp. Development
Exercised, kept
3,086
$3.77
$11.63K
HOLLER FRANK A
14 Mar 2018
Director
Exercised, kept
3,086
$3.77
$11.63K
PIMSTONE SIMON N.
12 Mar 2018
CEO
Exercised, kept
10,288
$3.77
$38.79K
COHEN CHARLES J.
12 Feb 2018
VP, Biology
Exercised, kept
26,748
$3.71
$99.24K
AZAB MOHAMMAD
15 Nov 2017
Director
Buy
15,000
$2.22
$33.28K
AZAB MOHAMMAD
22 Sep 2017
Director
Buy
8,000
$2.95
$23.60K
AZAB MOHAMMAD
21 Sep 2017
Director
Buy
2,000
$2.95
$5.90K
WINQUIST RAYMOND
18 Aug 2017
Head, Translational Research
Buy
1,000
$3.00
$3.00K
AZAB MOHAMMAD
18 Aug 2017
Director
Buy
6,312
$2.90
$18.30K
AZAB MOHAMMAD
17 Aug 2017
Director
Buy
23
$2.65
$60.95
BVF PARTNERS L P/IL
15 Aug 2017
10% owner
Buy
7,429
$2.41
$17.92K
BVF PARTNERS L P/IL
15 Aug 2017
10% owner
Buy
11,429
$2.41
$27.57K
EMPFIELD JAMES R.
15 Aug 2017
SVP, Drug Discovery
Buy
10,000
$2.48
$24.82K
Hayden Michael R
14 Aug 2017
Director
Buy
15,000
$2.75
$41.25K
Svoronos Dawn
14 Aug 2017
Director
Buy
50,000
$2.82
$140.77K
BVF PARTNERS L P/IL
14 Aug 2017
10% owner
Buy
13,337
$2.70
$36.06K
BVF PARTNERS L P/IL
14 Aug 2017
10% owner
Buy
28,007
$2.70
$75.72K
GANNON STEVEN
11 Aug 2017
Director
Buy
15,000
$2.82
$42.27K
PIMSTONE SIMON N.
10 Aug 2017
President & CEO
Buy
6,000
$2.90
$17.40K
SCHELLER RICHARD H
10 Aug 2017
Director
Buy
7,000
$2.85
$19.95K
MORTIMER IAN
10 Aug 2017
CFO & COO
Buy indirect
10,000
$2.90
$29.00K
MORTIMER IAN
10 Aug 2017
CFO & COO
Buy
5,000
$2.85
$14.23K
PATOU GARY
10 Aug 2017
Director
Buy indirect
7,500
$2.78
$20.84K
PATOU GARY
8 Aug 2017
Director
Buy indirect
5,000
$3.00
$15.00K
BVF PARTNERS L P/IL
27 Jun 2017
10% owner
Buy
8,496
$4.00
$33.98K
BVF PARTNERS L P/IL
27 Jun 2017
10% owner
Buy
30,170
$4.00
$120.68K
BVF PARTNERS L P/IL
27 Jun 2017
10% owner
Buy
46,795
$4.00
$187.18K
BVF PARTNERS L P/IL
22 Jun 2017
10% owner
Buy
854
$4.00
$3.42K
BVF PARTNERS L P/IL
22 Jun 2017
10% owner
Buy
2,884
$4.00
$11.54K
BVF PARTNERS L P/IL
22 Jun 2017
10% owner
Buy
4,525
$4.00
$18.10K
BVF PARTNERS L P/IL
21 Jun 2017
10% owner
Buy
1,362
$4.00
$5.45K
BVF PARTNERS L P/IL
21 Jun 2017
10% owner
Buy
4,406
$4.00
$17.62K
BVF PARTNERS L P/IL
21 Jun 2017
10% owner
Buy
6,380
$4.00
$25.52K
BVF PARTNERS L P/IL
19 Jun 2017
10% owner
Buy
357
$3.85
$1.37K
BVF PARTNERS L P/IL
19 Jun 2017
10% owner
Buy
1,271
$3.85
$4.89K
BVF PARTNERS L P/IL
19 Jun 2017
10% owner
Buy
1,967
$3.85
$7.57K
TARNOW MICHAEL M
19 Jun 2017
Director
Exercised, kept
1,028
$3.51
$3.61K
BVF PARTNERS L P/IL
16 Jun 2017
10% owner
Buy
1,064
$3.85
$4.10K
BVF PARTNERS L P/IL
16 Jun 2017
10% owner
Buy
3,873
$3.85
$14.91K
BVF PARTNERS L P/IL
16 Jun 2017
10% owner
Buy
6,097
$3.85
$23.47K
BVF PARTNERS L P/IL
15 Jun 2017
10% owner
Buy
1,160
$3.84
$4.45K
BVF PARTNERS L P/IL
15 Jun 2017
10% owner
Buy
3,845
$3.84
$14.75K
BVF PARTNERS L P/IL
15 Jun 2017
10% owner
Buy
6,774
$3.84
$25.99K
BVF PARTNERS L P/IL
7 Jun 2017
10% owner
Buy
20,594
$3.85
$79.31K
BVF PARTNERS L P/IL
7 Jun 2017
10% owner
Buy
73,749
$3.85
$284.02K
BVF PARTNERS L P/IL
7 Jun 2017
10% owner
Buy
113,446
$3.85
$436.90K
BVF PARTNERS L P/IL
6 Jun 2017
10% owner
Buy
913
$3.75
$3.42K
BVF PARTNERS L P/IL
6 Jun 2017
10% owner
Buy
53,260
$3.75
$199.73K
BVF PARTNERS L P/IL
6 Jun 2017
10% owner
Buy
96,736
$3.75
$362.76K
ROBIN SHERRINGTON
12 May 2017
SVP Bus. & Corp. Development
Exercised, kept
2,057
$3.21
$6.60K
Hayden Michael R
14 Mar 2017
Director
Exercised, kept indirect
3,086
$3.56
$10.99K
Hayden Michael R
14 Mar 2017
Director
Exercised, kept indirect
4,629
$3.07
$14.21K
Hayden Michael R
14 Mar 2017
Director
Exercised, kept indirect
4,115
$3.77
$15.51K
Hayden Michael R
14 Mar 2017
Director
Exercised, kept
5,144
$3.67
$18.88K
Hayden Michael R
14 Mar 2017
Director
Exercised, kept
25,720
$3.76
$96.71K
Hayden Michael R
14 Mar 2017
Director
Exercised, kept
18,004
$3.70
$66.61K
HOLLER FRANK A
15 Dec 2016
Director
Sell
30,000
$7.85
$235.50K
TARNOW MICHAEL M
12 Dec 2016
Director
Exercised, kept
14,403
$3.21
$46.23K
PATOU GARY
6 Dec 2016
Director
Exercised, kept
12,345
$3.21
$39.63K
AZAB MOHAMMAD
1 Dec 2016
Director
Exercised, kept
12,345
$3.21
$39.63K

What was left out

Form 4 filings counted 256
Amendments (4/A) skipped 3
Filings about a different issuer 0
Unreadable filings 0
Joint filings 6
Sales on a Rule 10b5-1 plan 14
Sales straight out of an exercise 64
Sales at will 33
Transactions with no price 0
Shares from compensation/vesting 4,418,692
Sales filed before the plan box existed 23
History held since 27 Sep 2016